Chronic kidney disease trials in Spain

In Spain 45 Also abroad 798

45 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Where
Barcelona
Age
1 year to 17 years
People
10 worldwide
Run by
Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00
Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
A Coruña, Almería, Badalona, L'hospitalet De Llobregat, Majadahonda, Málaga, Palma, Pamplona, Sevilla, Valencia
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
No phaseTaking people
Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors
Where
Salamanca
Age
16 years and over
People
300
Run by
Instituto de Investigación Biomédica de Salamanca
See details and how to joinNCT07348484
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Alzira, Andalucia, Badajoz, Badalona, Barcelona, Boadilla del Monte, Lugo, Majadahonda, Palma, Santander, Sevilla, Utrera Andalucia, Valencia, Valladolid
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Cadiz
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 2Taking people
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Where
Barcelona, Madrid
Age
12 years to 18 years
People
18 worldwide
Run by
Vifor Fresenius Medical Care Renal Pharma
See details and how to joinNCT06593392 · EU 2023-509909-74-00
Phase 4Not yet taking people in Spain
Efficacy and safety of Grafalon® versus Thymoglobulin® for induction therapy in kidney transplant recipients at high risk of delayed graft function: a phase IV randomized open-label study
Where
Valencia
Age
65 years and over
People
104
Run by
Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
See details and how to join2026-526938-23-00 · EU 2026-526938-23-00
Phase 4Taking people
CKD-bioMatch: A biomarker-targeted clinical trial to optimize treatment for patients with chronic kidney disease
Where
Valencia
Age
18 years and over
People
115 worldwide
Run by
Steno Diabetes Center Copenhagen
See details and how to join2023-507449-27-01 · EU 2023-507449-27-01
No phaseTaking people
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score
Where
Many Locations
Age
18 years and over
People
500
Run by
Bayer
See details and how to joinNCT07554469
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Barcelona, Pamplona, Salamanca
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Where
Badalona, Barcelona, Lleida, Murcia, Sevilla, Valencia, Zaragoza
Age
18 years and over
People
2,000 worldwide
Run by
The George Institute
See details and how to joinNCT06058585 · EU 2024-520253-21-00
Phase 1/2Taking people
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Where
Lleida
Age
18 years and over
People
75 worldwide
Run by
Oncorena AB
See details and how to joinNCT05287945
No phaseTaking people
Walnuts for Cardiorenal Protection in Adults With Chronic Kidney Disease
Where
Reus
Age
45 years to 75 years
People
150
Run by
Institut Investigacio Sanitaria Pere Virgili
See details and how to joinNCT07851454
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Barcelona, Esplugues De Llobregat, Madrid, Málaga, Sevilla
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Badajoz, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Talavera de la Reina, Valencia
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Alcobendas, Barcelona, Córdoba, Girona, Granada, Guadalajara, Lleida, Madrid, Manises, Palma de Mallorca, Santiago de Compostela, Seville, Terrassa, Valencia
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 2Taking people
A Phase IIb study to evaluate the effect of combination of dapagliflozin and baxdrostat compared with baxdrostat alone in participants with chronic kidney disease and high blood pressure
Where
Badalona, Madrid, Pamplona, Valencia
Age
18 years and over
People
18 worldwide
Run by
AstraZeneca AB
See details and how to join2025-522407-23-00 · EU 2025-522407-23-00
Phase 3Taking people
Keeping RAASi Treatment With Optimal Potassium Control
Where
Alicante, Barcelona, Madrid, Valencia
Age
18 years and over
People
78
Run by
Fundación para la Investigación del Hospital Clínico de Valencia
See details and how to joinNCT06578533
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Badajoz, Barcelona, Burgos, Córdoba, Granada, Madrid, Majadahonda, Málaga, Pamplona, Valencia
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Barcelona, Castilleja De La Cuesta, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Sevilla, Valencia, Zaragoza
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Taking people
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Where
Barcelona, Sevilla
Age
2 years to 17 years
People
24 worldwide
Run by
Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00
No phaseNot yet taking people in Spain
Remote vs In-Person Prehabilitation for Kidney Transplant Candidates
Where
Barcelona
Age
18 years and over
People
84
Run by
Hospital Clinic of Barcelona
See details and how to joinNCT07701382
No phaseTaking people
Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)
Where
Madrid
Age
18 years to 85 years
People
50
Run by
Cardenal Herrera University
See details and how to joinNCT07642778
Phase 1/2Taking people
Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Where
Barcelona
Age
18 years to 60 years
People
10
Run by
Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07607197 · EU 2023-506478-11-01
Phase 2Taking people
Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD)
Where
Badalona, Barcelona, L'hospitalet De Llobregat, Lugo, Madrid, Majadahonda, Pamplona, Sevilla, Valencia
Age
18 years and over
People
95 worldwide
Run by
Universitair Medisch Centrum Groningen
See details and how to join2025-525068-13-00 · EU 2025-525068-13-00